Protected Nucleosides
N4-isobutyryl-5'-O-(4, 4'-dimethoxytrityl)-2'-deoxycytidine
Quick view. We supply N4-isobutyryl-5'-O-(4, 4'-dimethoxytrityl)-2'-deoxycytidine as a protected nucleoside intermediate for DNA/RNA analog synthesis and medicinal chemistry workflows. CAS 100898-62-2. Catalog target purity: Specification on request.
Product profile
N4-isobutyryl-5'-O-(4, 4'-dimethoxytrityl)-2'-deoxycytidine is classified as nucleoside or protected nucleoside intermediate (Formula C34H37N3O7; molecular weight 599.67).
N4-isobutyryl-5'-O-(4, 4'-dimethoxytrityl)-2'-deoxycytidine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For N4-isobutyryl-5'-O-(4, 4'-dimethoxytrityl)-2'-deoxycytidine, storage: Store at 2-8°C.
Names and search terms
Confirmed or normalized name variants
- 5'-O-(Dimethoxytrityl)-N-isobutyryl-2'-deoxycytidine
- DMT-NIBU-DC
- N4-iBu-DMT-dC
- 5'-O-DMT-ibu-dC
- N4-(ISOBUTYRYL)-5'-O-(DIMETHOXYTRITYL)-2'-DEOXYCYTIDINE
- 5'-O-(4,4'-DIMETHOXYTRITYL)-N4-ISOBUTYRYL-2'-DEOXYCYTIDINE
- 5'-O-(4,4'-DIMETHOXYTRITYL)-N4-ISOBUTYRYL-2'-DEOXYCYTIDINE ISO 9001:2015 REACH
- Cytidine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-N-(2-methyl-1-oxopropyl)-
Useful catalog search terms
- CAS 100898-62-2
- Nucleoside or protected nucleoside intermediate
- Protected Nucleosides
Physicochemical data
| InChI | InChI=1S/C34H37N3O7/c1-4-8-31(39)35-30-19-20-37(33(40)36-30)32-21-28(38)29(44-32)22-43-34(23-9-6-5-7-10-23,24-11-15-26(41-2)16-12-24)25-13-17-27(42-3)18-14-25/h5-7,9-20,28-29,32,38H,4,8,21-22H2,1-3H3,(H,35,36,39,40)/t28-,29+,32+/m0/s |
|---|---|
| InChIKey | JAHWXECJHMFQQG-NPLMNSEMSA-N |
| SMILES | CCCC(=O)NC1=NC(=O)N(C=C1)[C@H]2C[C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O |
| Density | 1.25±0.1 g/cm3(Predicted) |
| pKa | 10.03±0.20(Predicted) |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
2'-O-TBDMS-rG(iBu)
Protected Nucleosides · CAS: 182007-86-9
BX-PN-00435'-O-DMTr-2'-O-TBDMS-rC(Ac)
Protected Nucleosides · CAS: 121058-85-3
BX-PN-00575'-O-TBDMS-3'-O-TBDMS-5-(hydroxymethyl)-dC
Protected Nucleosides · CAS: 1257247-39-4
BX-PN-00585'-O-TBDMS-3'-O-TBDMS-5-I-dC
Protected Nucleosides · CAS: 478843-96-8
BX-PN-00607'-O-TBDMS-4'-N-Trt-PMO-G(iBu)
Protected Nucleosides · CAS: N/A
BX-PN-00673'-O-TBDMS-2'-F-dG(iBu)
Protected Nucleosides · CAS: 2382967-92-0
Frequently asked questions
Can the package size for N4-isobutyryl-5'-O-(4, 4'-dimethoxytrityl)-2'-deoxycytidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-PN-0118 and CAS 100898-62-2, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Protected Nucleosides product family and its named chemistry.